U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H44O9
Molecular Weight 548.665
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYMARIN

SMILES

[H][C@@]1(C[C@H](OC)[C@H](O)[C@@H](C)O1)O[C@H]2CC[C@]3(C=O)[C@@]4([H])CC[C@]5(C)[C@H](CC[C@]5(O)[C@]4([H])CC[C@]3(O)C2)C6=CC(=O)OC6

InChI

InChIKey=XQCGNURMLWFQJR-ZNDDOCHDSA-N
InChI=1S/C30H44O9/c1-17-26(33)23(36-3)13-25(38-17)39-19-4-9-28(16-31)21-5-8-27(2)20(18-12-24(32)37-15-18)7-11-30(27,35)22(21)6-10-29(28,34)14-19/h12,16-17,19-23,25-26,33-35H,4-11,13-15H2,1-3H3/t17-,19+,20-,21+,22-,23+,25+,26-,27-,28+,29+,30+/m1/s1

HIDE SMILES / InChI

Molecular Formula C30H44O9
Molecular Weight 548.665
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 0
Optical Activity UNSPECIFIED

Cymarin (or cymarine or k-strophanthidin-alpha) is a cardiac glycoside and an anti-arrhythmia and cardiotonic agent. Cymarin works as an inhibitor of Na+ /K+-ATPase . This inhibition has an inotropic effect on the cardiac muscles increasing their force by approximately 100%.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Cardiotonic effect of Apocynum venetum L. extracts on isolated guinea pig atrium.
2009 Apr
Patents

Patents

Sample Use Guides

Unknown
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:50:35 GMT 2023
Edited
by admin
on Fri Dec 15 18:50:35 GMT 2023
Record UNII
UK3LS8435E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CYMARIN
MART.   MI   WHO-DD  
Common Name English
CYMARIN [MI]
Common Name English
Cymarin [WHO-DD]
Common Name English
CYMARINE
Common Name English
K-STROPHANTHIN-ALPHA
Common Name English
K-STROPHANTHIN-.ALPHA.
Common Name English
3.BETA.-((2,6-DIDEOXY-3-O-METHYL-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-5,14-DIHYDROXY-19-OXO-5.BETA.,14.BETA.-CARD-20(22)-ENOLIDE
Common Name English
NSC-7522
Code English
CYMARIN [MART.]
Common Name English
Classification Tree Code System Code
WHO-ATC C01AC03
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
WHO-VATC QC01AC03
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
Code System Code Type Description
MESH
D003529
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
ECHA (EC/EINECS)
208-087-9
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
DRUG BANK
DB13240
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID20871714
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
MERCK INDEX
m4028
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY Merck Index
CAS
508-77-0
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
WIKIPEDIA
CYMARIN
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
ChEMBL
CHEMBL1651908
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
NSC
7522
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
PUBCHEM
441853
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
FDA UNII
UK3LS8435E
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY
DRUG CENTRAL
4408
Created by admin on Fri Dec 15 18:50:35 GMT 2023 , Edited by admin on Fri Dec 15 18:50:35 GMT 2023
PRIMARY